Chief, Division of Cardiology, Director Heart Center
Durham, North Carolina
Chief of the Division of Cardiology and Director of the Duke Heart Center across Duke University Health System. I am an interventional cardiologist and Professor of Medicine at the Duke University Medical Center and Duke Clinical Research Institute. My research interests include evaluating novel therapeutics including devices and diagnostic technologies for patients with coronary and peripheral vascular disease. I have been involved in conducting clinical trials and outcomes assessments of technologies and therapeutics aimed at patients with coronary and vascular disease. I was recently the principal Investigator for the Coordinating Center for the EUCLID trial, a 14,000 patient randomized trial comparing ticagrelor with clopidogrel for cardiovascular outcomes in patients with peripheral artery disease, site principle investigator of the PORTRIAT registry, a PCORI funded registry of patients with PAD and their reported symptoms, a principle investigator for SYPRAL, a 200 patient randomized trial evaluating renal denervation for hypertension patients, and principle investigator for ADVANCE, a 5000 patient registry evaluating the role of CT-FFR in patients with chest pain in practice. I was Co-PI of the NHBLI funded PROMISE trial evaluating functional testing vs. anatomic testing in patients with chest pain. Beyond these current studies, I am involved in a group that has used administrative claims data, electronic health data, and registry data to understand the care patterns and outcome of patients with cardiovascular disease. On a national level, I am the past Chair of the ACC Task Force for Appropriate Use and Chair of the AHA Diagnostic and Interventional Cath Committee. Clinically, I see and care for patients with coronary and vascular disease with a focus on therapies and procedures to improve outcomes.